These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8388461

  • 21. N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.
    Berardi F, Santoro S, Perrone R, Tortorella V, Govoni S, Lucchi L.
    J Med Chem; 1998 Oct 08; 41(21):3940-7. PubMed ID: 9767631
    [Abstract] [Full Text] [Related]

  • 22. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL, Cordon JJ.
    J Pharmacol Exp Ther; 1997 Feb 08; 280(2):584-92. PubMed ID: 9023267
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y, Hammond PS, Whirrett BR, Kuhner RJ, Wu L, Childers SR, Mach RH.
    J Med Chem; 1998 Jun 18; 41(13):2361-70. PubMed ID: 9632369
    [Abstract] [Full Text] [Related]

  • 24. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents.
    Klein M, Musacchio JM.
    J Pharmacol Exp Ther; 1989 Oct 18; 251(1):207-15. PubMed ID: 2477524
    [Abstract] [Full Text] [Related]

  • 25. Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter.
    Husbands SM, Izenwasser S, Loeloff RJ, Katz JL, Bowen WD, Vilner BJ, Newman AH.
    J Med Chem; 1997 Dec 19; 40(26):4340-46. PubMed ID: 9435903
    [Abstract] [Full Text] [Related]

  • 26. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes.
    Garza HH, Mayo S, Bowen WD, DeCosta BR, Carr DJ.
    J Immunol; 1993 Nov 01; 151(9):4672-80. PubMed ID: 7691955
    [Abstract] [Full Text] [Related]

  • 27. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
    Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Dubuffet T, Lavielle G.
    J Pharmacol Exp Ther; 2000 Jun 01; 293(3):1048-62. PubMed ID: 10869410
    [Abstract] [Full Text] [Related]

  • 28. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA, DiCarlo JJ, Zhang Y, Thompson P, Meltzer HY.
    J Pharmacol Exp Ther; 1993 Sep 01; 266(3):1374-84. PubMed ID: 8103793
    [Abstract] [Full Text] [Related]

  • 29. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
    Skuza G, Kolasiewicz W, Dziedzicka-Wasylewska M, Margas W.
    Pol J Pharmacol; 1998 Sep 01; 50(6):399-406. PubMed ID: 10385922
    [Abstract] [Full Text] [Related]

  • 30. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
    Cao J, Kulkarni SS, Husbands SM, Bowen WD, Williams W, Kopajtic T, Katz JL, George C, Newman AH.
    J Med Chem; 2003 Jun 19; 46(13):2589-98. PubMed ID: 12801223
    [Abstract] [Full Text] [Related]

  • 31. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 19; 280(1):83-97. PubMed ID: 8996185
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
    Merchant KM, Gill GS, Harris DW, Huff RM, Eaton MJ, Lookingland K, Lutzke BS, Mccall RB, Piercey MF, Schreur PJ, Sethy VH, Smith MW, Svensson KA, Tang AH, Vonvoigtlander PF, Tenbrink RE.
    J Pharmacol Exp Ther; 1996 Dec 19; 279(3):1392-403. PubMed ID: 8968364
    [Abstract] [Full Text] [Related]

  • 33. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.
    Matsuno K, Matsunaga K, Senda T, Mita S.
    J Pharmacol Exp Ther; 1993 May 19; 265(2):851-9. PubMed ID: 8496830
    [Abstract] [Full Text] [Related]

  • 34. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh HY, Kong JY.
    Pharmacol Biochem Behav; 2005 Oct 19; 82(2):361-72. PubMed ID: 16216322
    [Abstract] [Full Text] [Related]

  • 35. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
    Bailey MA, Karbon EW.
    Eur J Pharmacol; 1993 Aug 24; 240(2-3):243-50. PubMed ID: 7902283
    [Abstract] [Full Text] [Related]

  • 36. Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
    Musacchio JM, Klein M, Paturzo JJ.
    Mol Pharmacol; 1989 Jan 24; 35(1):1-5. PubMed ID: 2536463
    [Abstract] [Full Text] [Related]

  • 37. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar 24; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 38. Sigma receptors in post-mortem human brains.
    Weissman AD, Su TP, Hedreen JC, London ED.
    J Pharmacol Exp Ther; 1988 Oct 24; 247(1):29-33. PubMed ID: 2845055
    [Abstract] [Full Text] [Related]

  • 39. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB, Terranova MA, Chang R, Uchic ME, Matulenko MA, Surber BW, Stewart AO, Brioni JD.
    Eur J Pharmacol; 2004 Aug 23; 497(2):147-54. PubMed ID: 15306199
    [Abstract] [Full Text] [Related]

  • 40. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
    Itzhak Y, Ali SF.
    Ann N Y Acad Sci; 1998 May 30; 844():245-51. PubMed ID: 9668682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.